Founded by data scientists, clinicians, and microbiologists from MIT and OpenBiome, Finch uses machine - learning algorithms informed by high - throughput molecular data to reverse engineer successful experiences
with fecal transplantation.
Not exact matches
Prof. Severine Vermeire (KU Leuven / UZ Leuven): «In the future, gut bacteria may be used to help identify PSC patients
with a more or less aggressive disease, or patients that may benefit from microbiota - based therapies, such as
fecal microbiota
transplantation or targeted pre - and probiotics.»
A team led by gastroenterologists Sieglinde Angelberger and Walter Reinisch (Medical University Vienna) and microbiologists David Berry and Alexander Loy (University of Vienna) explored how a treatment called «
fecal microbiota
transplantation» can be used to support microbial recolonization of the gut of patients
with chronic intestinal inflammation (ulcerative colitis).
«Meta studies have shown that the controlled grafting of
fecal transplantation from healthy donors is a safe and very effective treatment of acute diarrheal diseases caused by the pathogenic bacterium Clostridium difficile,» said Sieglinde Angelberger, gastroenterologist at the University Clinic for Internal Medicine III of the Medical University of Vienna and author of the study: «this was the reason why we applied this therapy for the treatment of patients
with chronic intestinal diseases.»
«
Fecal microbiota
transplantation has been very successful for many patients
with C. difficile infections, but we've never known why.
«This is the first randomised trial to show that
fecal transplantation may be of benefit to patients
with hepatic encephalopathy.
Fecal microbiota
transplantation induces remission in patients
with active ulcerative colitis in a randomized controlled trial.
Effect of Vegan
Fecal Microbiota
Transplantation on Carnitine and Choline ‐ Derived Trimethylamine ‐ N ‐ Oxide Production and Vascular Inflammation in Patients
With Metabolic Syndrome — Loek P. Smits — Journal of the American Heart Association
«To preserve patient access to this treatment option, and given the scale that we've reached, demonstrating the safety and efficacy of
fecal transplantation through adequate and well - controlled clinical trials is the right thing to do,» explained Carolyn Edelstein, OpenBiome's director of Outreach and Public Affairs, in an op - ed published earlier today with the Fecal Transplant Founda
fecal transplantation through adequate and well - controlled clinical trials is the right thing to do,» explained Carolyn Edelstein, OpenBiome's director of Outreach and Public Affairs, in an op - ed published earlier today
with the
Fecal Transplant Founda
Fecal Transplant Foundation.
Fecal microbiota
transplantation in puppies
with canine parvovirus infection — Giorgio Q. Pereira — Journal of Veterinary Internal Medicine
OpenBiome was founded to expand safe access to
fecal transplantation for patients
with recurrent C. difficile infection and to catalyze research on the role of the microbiome in human health.
«Through it, we will provide safe access to
fecal transplantation for patients
with recurrent C. difficile today, and help Finch pursue FDA approval so that patients have this access in perpetuity.
About OpenBiome OpenBiome is the first public stool bank, founded to expand safe access to
fecal transplantation for patients
with recurrent C. difficile infection and to catalyze research on the microbiome's role in human health.
Successful
Fecal Microbiota
Transplantation in a Patient
with Severe Complicated Clostridium difficile Infection after Liver
Transplantation
Probiotics / prebiotics / antibiotics Tacrolimus concentration to dose ratio in solid organ transplant patients treated
with fecal microbiota
transplantation for recurrent Clostridium difficile infection.
The first study of the social and ethical issues associated
with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called «
fecal microbiota
transplantation» to become available, although many have concerns about donor selection, screening, and methods of delivery.
June 2, 2011 Patients
with bowel disease eager to test «
fecal» therapy The first study of the social and ethical issues associated
with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called «
fecal microbiota
transplantation» to become available, although many have concerns about donor selection, screening, and methods of delivery.
Like an organ transplant,
fecal microbiota
transplantation begins
with finding a donor, often a family member.
Dr. Davis is one of a handful of physicians in North America
with clinical expertise in
fecal microbiota
transplantation (FMT), which he offers via retention enema and capsule.
The purpose of this study was to determine if
fecal transplantation could be used to cure Clostridium perfringens infections that were not cured by treatment
with metronidazole and amoxicillin trihydrate / clavulanate potassium.